1. Home
  2. EQ vs CSTE Comparison

EQ vs CSTE Comparison

Compare EQ & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EQ

Equillium Inc.

HOLD

Current Price

$1.19

Market Cap

57.8M

Sector

Health Care

ML Signal

HOLD

CSTE

Caesarstone Ltd.

HOLD

Current Price

$2.03

Market Cap

60.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQ
CSTE
Founded
2017
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
57.8M
60.2M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
EQ
CSTE
Price
$1.19
$2.03
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
$1.00
$5.00
AVG Volume (30 Days)
1.1M
107.2K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,392,000.00
$400,656,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.86
52 Week High
$2.35
$4.67

Technical Indicators

Market Signals
Indicator
EQ
CSTE
Relative Strength Index (RSI) 46.21 63.65
Support Level $1.12 $1.67
Resistance Level $1.61 $2.02
Average True Range (ATR) 0.20 0.19
MACD -0.03 0.01
Stochastic Oscillator 18.60 78.02

Price Performance

Historical Comparison
EQ
CSTE

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: